Insulin Dose Adjustment for Hyperglycemia

Initial Assessment and Approach

For patients with persistent hyperglycemia, the American Diabetes Association recommends initiating insulin therapy after confirming elevated glucose on two occasions, with a target glucose range of 140-180 mg/dL for most hospitalized patients 3, 4
The American Diabetes Association suggests that more stringent targets, such as 110-140 mg/dL, may be appropriate for selected patients, such as those post-cardiac surgery, if achievable without significant hypoglycemia 3, 4

For patients on basal insulin, the American Diabetes Association recommends increasing the basal insulin dose by 2 units every 3 days until fasting plasma glucose target is reached without hypoglycemia, and reducing the dose by 10-20% if hypoglycemia occurs 1, 2, 5
For patients on prandial insulin, the American Diabetes Association suggests increasing the prandial insulin dose by 1-2 units or 10-15% twice weekly, with an initial prandial insulin dose of 4 units per day or 10% of the basal insulin dose 2, 6
For insulin-naïve patients, the American Diabetes Association recommends starting with 10 units per day of basal insulin or 0.1-0.2 units/kg per day, and considering a total daily insulin dose of 0.3-0.5 units/kg for patients requiring prandial coverage 1, 2, 7, 8

For hospitalized patients with higher doses of insulin at home, the American Diabetes Association suggests reducing the total daily insulin dose by 20% to prevent hypoglycemia due to poor oral intake, and considering a basal-plus approach with a single dose of basal insulin for patients with mild hyperglycemia 7, 8, 9
For patients on NPH insulin, the American Diabetes Association recommends converting from bedtime NPH to twice-daily NPH using 80% of the current bedtime NPH dose, and adding prandial insulin to the NPH regimen with 4 units of short/rapid-acting insulin or 10% of the reduced NPH dose 1, 2, 5

The American Diabetes Association recommends assessing the adequacy of insulin dose at every visit, monitoring for signs of overbasalization, and performing point-of-care glucose monitoring before meals for hospitalized patients who are eating 1, 2, 3
For patients with elevated A1C despite basal insulin optimization, the American Diabetes Association suggests considering adding GLP-1 RA or progressing to prandial insulin coverage 1, 5

The American Diabetes Association recommends lowering insulin doses by 10-20% for patients at higher risk of hypoglycemia, such as the elderly or those with renal failure, and avoiding sliding scale insulin alone for patients with type 1 diabetes or significant hyperglycemia 7, 8